Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)
CNY 36.2
(-3.13%)
CNY 36.2
(-3.13%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 318.28 Million CNY | -0.22% |
| 2022 | 324 Million CNY | 15.31% |
| 2021 | 281.28 Million CNY | 12.23% |
| 2020 | 233.89 Million CNY | 64.87% |
| 2019 | 144.03 Million CNY | -18.38% |
| 2018 | 173.89 Million CNY | 77.39% |
| 2017 | 98.43 Million CNY | 57.35% |
| 2016 | 61.61 Million CNY | 2.8% |
| 2015 | 61.33 Million CNY | 41.62% |
| 2014 | 43.3 Million CNY | 103.37% |
| 2013 | 21.29 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 80.4 Million CNY | 102.18% |
| 2024 Q2 | 83.08 Million CNY | -1.15% |
| 2024 Q3 | 72.7 Million CNY | -28.22% |
| 2023 Q4 | 30.47 Million CNY | -53.0% |
| 2023 FY | - CNY | -0.22% |
| 2023 Q3 | 64.84 Million CNY | -10.11% |
| 2023 Q2 | 72.13 Million CNY | 10.72% |
| 2023 Q1 | 65.15 Million CNY | 24.1% |
| 2022 Q2 | 81.69 Million CNY | 59.98% |
| 2022 Q1 | 51.06 Million CNY | 17.05% |
| 2022 FY | - CNY | 15.31% |
| 2022 Q4 | 52.5 Million CNY | -16.54% |
| 2022 Q3 | 62.9 Million CNY | -22.99% |
| 2021 Q2 | 72.06 Million CNY | 57.57% |
| 2021 Q1 | 45.73 Million CNY | -21.42% |
| 2021 FY | - CNY | 12.23% |
| 2021 Q3 | 71.79 Million CNY | -0.38% |
| 2021 Q4 | 43.62 Million CNY | -39.23% |
| 2020 FY | - CNY | 64.87% |
| 2020 Q1 | 176.41 Million CNY | 1629.78% |
| 2020 Q2 | -77.37 Million CNY | -143.86% |
| 2020 Q3 | 45.1 Million CNY | 158.3% |
| 2020 Q4 | 58.2 Million CNY | 29.03% |
| 2019 Q3 | 14.52 Million CNY | 111.75% |
| 2019 Q2 | -123.56 Million CNY | -158.6% |
| 2019 Q1 | 210.85 Million CNY | 0.0% |
| 2019 FY | - CNY | -18.38% |
| 2019 Q4 | 10.19 Million CNY | -29.79% |
| 2018 FY | - CNY | 77.39% |
| 2017 FY | - CNY | 57.35% |
| 2016 FY | - CNY | 2.8% |
| 2016 Q1 | 18.71 Million CNY | 32.82% |
| 2016 Q2 | 18.71 Million CNY | 0.0% |
| 2015 Q2 | 13.75 Million CNY | -0.0% |
| 2015 Q1 | 13.75 Million CNY | 0.0% |
| 2015 Q4 | 14.09 Million CNY | 0.0% |
| 2015 FY | - CNY | 41.62% |
| 2014 FY | - CNY | 103.37% |
| 2013 FY | - CNY | 0.0% |